V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20026377 | 20011220 | 1.72 | 103.2 | Not known (9) | 2013-05-30 | 2013-05-31 | FEC 100 + DOCETAXEL | 02 | N | 20092971 | FEC + DOCETAXEL |
| 20026378 | 20011220 | 1.68 | 68 | Adjuvant (A) | 2013-04-10 | 2013-04-19 | FEC + DOCETAXEL | N | N | 20092971 | FEC + DOCETAXEL |
| 20026379 | 20011220 | 1.6 | 66.1 | Adjuvant (A) | 2017-08-24 | 2017-08-31 | FEC + DOCETAXEL | 02 | N | 20092971 | FEC + DOCETAXEL |
| 20026380 | 20011221 | 1.59 | 66 | Neo-adjuvant (N) | 2014-02-02 | 2014-02-08 | FEC 100 + DOCETAXEL | 2 | N | 20092987 | FEC + DOCETAXEL |
| 20026381 | 20011222 | 0 | 68 | Adjuvant (A) | 2015-02-06 | 2015-02-26 | FEC + DOCETAXEL | 02 | N | 20092989 | FEC + DOCETAXEL |
| 20026382 | 20011222 | 1.72 | 78.8 | Neo-adjuvant (N) | 2013-12-30 | 2014-01-05 | FEC 100 + DOCETAXEL | N | N | 20092989 | FEC + DOCETAXEL |
| 20026383 | 20011222 | 1.68 | 84 | Adjuvant (A) | 2014-12-13 | 2014-12-13 | FEC + DOCETAXEL | 2 | N | 20092989 | FEC + DOCETAXEL |
| 20026384 | 20011222 | null | 57.6 | Adjuvant (A) | 2014-02-12 | 2014-02-26 | FEC + DOCETAXEL | Y | N | 20092989 | FEC + DOCETAXEL |
| 20026385 | 20011223 | 1.58 | null | Adjuvant (A) | 2014-08-11 | 2014-08-11 | FEC 100 + DOCETAXEL | N | N | 20093008 | FEC + DOCETAXEL |
| 20026386 | 20011224 | null | 62.4 | Neo-adjuvant (N) | 2013-11-17 | 2013-12-10 | FEC 100 + DOCETAXEL | N | N | 20093011 | FEC + DOCETAXEL |
| 20026387 | 20011224 | 1.67 | 77.4 | Adjuvant (A) | 2017-08-04 | 2017-08-17 | FEC 100 + DOCETAXEL | 2 | N | 20093011 | FEC + DOCETAXEL |
| 20026388 | 20011225 | 1.64 | 123.1 | Adjuvant (A) | 2015-04-25 | 2015-04-25 | FEC + DOCETAXEL | 02 | N | 20093015 | FEC + DOCETAXEL |
| 20026389 | 20011226 | null | 65 | Adjuvant (A) | 2017-05-15 | 2017-06-06 | FEC + DOCETAXEL | N | N | 20093016 | FEC + DOCETAXEL |
| 20026390 | 20071612 | 1.6 | 65.05 | Neo-adjuvant (N) | 2013-10-23 | 2013-10-23 | FEC 100 + DOCETAXEL | 02 | N | 20093017 | FEC + DOCETAXEL |
| 20026391 | 20011227 | 1.64 | 58.5 | Adjuvant (A) | 2015-03-26 | 2015-03-26 | FEC 100 + DOCETAXEL | 02 | N | 20093019 | FEC + DOCETAXEL |
| 20026392 | 20011228 | 1.58 | 62.1 | Curative (C) | 2015-05-12 | 2015-05-14 | FEC 100 + DOCETAXEL | 02 | N | 20093035 | FEC + DOCETAXEL |
| 20026393 | 20011229 | 1.62 | 62.65 | Adjuvant (A) | 2016-11-18 | 2016-11-22 | FEC + DOCETAXEL | 02 | null | 20093038 | FEC + DOCETAXEL |
| 20026394 | 20011229 | null | 65 | Neo-adjuvant (N) | 2014-03-03 | 2014-03-11 | FEC + DOCETAXEL | 02 | N | 20093038 | FEC + DOCETAXEL |
| 20026395 | 20011229 | 1.67 | 77 | Adjuvant (A) | 2016-04-08 | 2016-04-10 | FEC + DOCETAXEL | 02 | N | 20093038 | FEC + DOCETAXEL |
| 20026396 | 20011230 | 1.69 | 48 | Adjuvant (A) | 2016-11-10 | 2016-11-25 | FEC + DOCETAXEL | N | N | 20093055 | FEC + DOCETAXEL |
| 20026397 | 20011231 | null | 145.5 | Adjuvant (A) | 2016-03-23 | 2016-04-06 | FEC + DOCETAXEL | N | N | 20093057 | FEC + DOCETAXEL |
| 20026398 | 20011231 | null | 73 | Neo-adjuvant (N) | 2014-10-23 | 2014-11-07 | FEC + DOCETAXEL | N | N | 20093057 | FEC + DOCETAXEL |
| 20026399 | 20011232 | 1.74 | 77.75 | Adjuvant (A) | 2017-12-15 | 2017-12-15 | FEC + DOCETAXEL | 02 | N | 20093069 | FEC + DOCETAXEL |
| 20026400 | 20011232 | 1.62 | 69.1 | Adjuvant (A) | 2017-10-24 | 2017-11-07 | FEC + DOCETAXEL | N | N | 20093069 | FEC + DOCETAXEL |
| 20026401 | 20011233 | 1.56 | 117 | Adjuvant (A) | 2018-03-05 | 2018-03-09 | FEC 100 + DOCETAXEL | N | N | 20093080 | FEC + DOCETAXEL |
| 20026402 | 20011233 | 1.68 | null | Adjuvant (A) | 2014-07-30 | 2014-08-14 | FEC + DOCETAXEL | 99 | null | 20093080 | FEC + DOCETAXEL |
| 20026403 | 20011234 | 1.67 | 90 | Adjuvant (A) | 2014-11-20 | 2014-12-16 | FEC + DOCETAXEL | 99 | N | 20093089 | FEC + DOCETAXEL |
| 20026404 | 20071617 | 1.68 | 53 | Adjuvant (A) | 2017-10-21 | 2017-10-24 | FEC + DOCETAXEL | 02 | N | 20093099 | FEC + DOCETAXEL |
| 20026405 | 20071617 | 1.59 | 75.5 | Adjuvant (A) | 2016-04-16 | 2016-05-02 | FEC + DOCETAXEL | 02 | N | 20093099 | FEC + DOCETAXEL |
| 20026406 | 20127879 | 1.66 | 87 | Curative (C) | null | 2017-06-15 | FEC + DOCETAXEL | N | N | 20093102 | FEC + DOCETAXEL |
| 20026407 | 20011235 | 1.65 | 63.7 | Adjuvant (A) | 2014-03-06 | 2014-03-15 | FEC + DOCETAXEL | 02 | N | 20093103 | FEC + DOCETAXEL |
| 20026408 | 20011235 | 1.66 | 86.2 | Adjuvant (A) | 2017-07-27 | 2017-07-27 | FEC + DOCETAXEL | 2 | N | 20093103 | FEC + DOCETAXEL |
| 20026409 | 20011235 | 1.65 | 60 | Adjuvant (A) | 2015-08-15 | 2015-08-29 | FEC + DOCETAXEL | N | null | 20093103 | FEC + DOCETAXEL |
| 20026410 | 20011235 | null | 105.8 | Palliative (P) | 2016-04-18 | 2016-04-23 | FEC + DOCETAXEL | 2 | N | 20093103 | FEC + DOCETAXEL |
| 20026411 | 20011236 | 0.79 | null | Neo-adjuvant (N) | 2017-09-27 | 2017-09-27 | FEC + DOCETAXEL | N | N | 20093117 | FEC + DOCETAXEL |
| 20026412 | 20011236 | 1.47 | null | Adjuvant (A) | null | 2016-04-10 | FEC + DOCETAXEL | 99 | null | 20093117 | FEC + DOCETAXEL |
| 20026413 | 20011236 | 1.58 | 72 | Not known (9) | 2016-05-06 | 2016-05-16 | FEC + DOCETAXEL | 02 | N | 20093117 | FEC + DOCETAXEL |
| 20026414 | 20011237 | 1.56 | 66.8 | Adjuvant (A) | 2015-02-21 | 2015-02-21 | FEC + DOCETAXEL | N | N | 20093123 | FEC + DOCETAXEL |
| 20026415 | 20011237 | 1.72 | 87 | Neo-adjuvant (N) | 2014-08-10 | 2014-08-11 | FEC + DOCETAXEL | 02 | null | 20093123 | FEC + DOCETAXEL |
| 20026416 | 20011237 | 1.55 | 63.4 | Neo-adjuvant (N) | 2015-09-17 | 2015-10-03 | FEC 100 + DOCETAXEL | 02 | N | 20093123 | FEC + DOCETAXEL |
| 20026417 | 20011238 | 1.62 | 81.4 | Adjuvant (A) | 2017-03-05 | 2017-03-08 | FEC + DOCETAXEL | 2 | null | 20093133 | FEC + DOCETAXEL |
| 20026418 | 20011238 | 1.63 | 77.4 | Neo-adjuvant (N) | 2013-04-23 | 2013-05-15 | FEC 100 + DOCETAXEL | 02 | null | 20093133 | FEC + DOCETAXEL |
| 20026419 | 20011238 | 1.68 | 80 | Curative (C) | 2016-07-06 | 2016-07-06 | FEC + DOCETAXEL | 2 | N | 20093133 | FEC + DOCETAXEL |
| 20026420 | 20011238 | null | null | Adjuvant (A) | 2018-01-02 | 2018-01-09 | FEC + DOCETAXEL | N | N | 20093133 | FEC + DOCETAXEL |
| 20026421 | 20011238 | 1.82 | 58.58 | Adjuvant (A) | 2017-03-21 | 2017-04-07 | FEC + DOCETAXEL | 02 | N | 20093133 | FEC + DOCETAXEL |
| 20026422 | 20011238 | 1.54 | 90.2 | Neo-adjuvant (N) | null | 2015-06-29 | FEC + DOCETAXEL | N | N | 20093133 | FEC + DOCETAXEL |
| 20026423 | 20011239 | 1.68 | null | Adjuvant (A) | 2015-02-28 | 2015-03-21 | FEC 100 + DOCETAXEL | N | N | 20093150 | FEC + DOCETAXEL |
| 20026424 | 20011240 | 1.56 | 93 | Adjuvant (A) | 2017-09-28 | 2017-10-11 | FEC + DOCETAXEL | 02 | null | 20093152 | FEC + DOCETAXEL |
| 20026425 | 20071622 | 1.62 | null | Adjuvant (A) | 2013-08-14 | 2013-08-25 | FEC 100 + DOCETAXEL | N | N | 20093154 | FEC + DOCETAXEL |
| 20026426 | 20071622 | 1.65 | 86.6 | Adjuvant (A) | 2016-01-15 | 2016-01-15 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20093154 | FEC + DOCETAXEL |